The Predicament of Poorly Differentiated NSCLC/NSCLC NOS
A topic that came up in a recent expert round table case discussion was the issue of how to manage a patient with a lung cancer for which the pathology report says "NSCLC not otherwise specified (NOS)", or "poorly differentiated NSCLC, NOS". What does this actually mean, and what does it mean in terms of treatment options?